0001209191-19-043330.txt : 20190726
0001209191-19-043330.hdr.sgml : 20190726
20190726161436
ACCESSION NUMBER: 0001209191-19-043330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS ROBERT T. JR.
CENTRAL INDEX KEY: 0001563606
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 19978227
MAIL ADDRESS:
STREET 1: INTEGRA LIFESCIENCES CORPORATION
STREET 2: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-24
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001563606
DAVIS ROBERT T. JR.
311 C ENTERPRISE DRIVE
PLAINSBORO
NJ
08536
0
1
0
0
CVP,PRES-ORTHO & TISSUE TECH
Common Stock
2019-07-24
4
S
0
11234
63.135
D
37272
D
Common Stock
2019-07-24
4
M
0
4698
26.865
A
41970
D
Common Stock
2019-07-24
4
S
0
4698
63.00
D
37272
D
Common Stock
2019-07-24
4
M
0
5052
32.585
A
42324
D
Common Stock
2019-07-24
4
S
0
5052
63.00
D
37272
D
Non-Qualified Stock Option (right to buy)
26.865
2019-07-24
4
M
0
4698
0.00
D
2023-03-23
Common Stock
4698
1566
D
Non-Qualified Stock Option (right to buy)
32.585
2019-07-24
4
M
0
5052
0.00
D
2024-03-14
Common Stock
5052
8736
D
The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015.
This stock option was previously reported as covering 2,710 shares of common stock at an exercise price of $62.10 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/14/2016.
In accordance with the terms of the stock option plan, the exercise price of the
option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
Eric Schwartz; Attorney-in-Fact
2019-07-26